Combined Inhibition of Complement and CD14 Efficiently Attenuated the Inflammatory Response Induced by Staphylococcus aureus in a Human Whole Blood Model

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Immunology

• Publication date

  2014-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1300755PMID 24516199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties.

  2013cited by this paper
• Accessory molecules for Toll-like receptors and their function

  2012cited by this paper
• The function of TLR2 during staphylococcal diseases

  2012cited by this paper
• Staphylococcus aureus Induces Type I IFN Signaling in Dendritic Cells Via TLR9

  2012cited by this paper
• Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.

  2012cited by this paper
• Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.

  2012cited by this paper
• After Xigris, researchers look to new targets to combat sepsis

  2012cited by this paper
• Crosstalk between Complement and Toll-Like Receptors

  2012cited by this paper
• Complement takes its Toll: an inflammatory crosstalk between Toll‐like receptors and the receptors for the complement anaphylatoxin C5a

  2012cited by this paper
• Chemical synthesis of bacterial lipoteichoic acids: an insight on its biological significance.

  2011cited by this paper
• Differences in Toll-like receptor expression and cytokine production after stimulation with heat-killed Gram-positive and Gram-negative bacteria

  2011cited by this paper
• Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

  2011cited by this paper
• Differences in Toll-like receptor expression and cytokine production after stimulation with heat-killed gram-positive and gram-negative bacteria

  2011influential reference
• ATF6β is a host cellular target of the Toxoplasma gondii virulence factor ROP18

  2011cited by this paper
• CD14 is a coreceptor of Toll-like receptors 7 and 9

  2010cited by this paper
• Phagocytosis and Phagosome Acidification Are Required for Pathogen Processing and MyD88-Dependent Responses to Staphylococcus aureus

  2010cited by this paper
• Microbial Hijacking of Complement–Toll-Like Receptor Crosstalk

  2010cited by this paper
• Complement: a key system for immune surveillance and homeostasis

  2010cited by this paper
• Comparative Kinetics of Escherichia coli- and Staphylococcus aureus-Specific Activation of Key Immune Pathways in Mammary Epithelial Cells Demonstrates That S. aureus Elicits a Delayed Response Dominated by Interleukin-6 (IL-6) but Not by IL-1A or Tumor Necrosis Factor Alpha

  2010cited by this paper
• The roles of TLRs, RLRs and NLRs in pathogen recognition.

  2009cited by this paper
• Human genetic deficiencies reveal the roles of complement in the inflammatory network: Lessons from nature

  2009influential reference
• High Levels of mecA DNA Detected by a Quantitative Real-Time PCR Assay Are Associated with Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia

  2009cited by this paper
• Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood.

  2008cited by this paper
• The epidemiology of sepsis.

  2008cited by this paper
• TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice

  2008cited by this paper
• The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008.

  2008cited by this paper
• Platelets augment respiratory burst in neutrophils activated by selected species of gram-positive or gram-negative bacteria.

  2008cited by this paper
• Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response.

  2008cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria.

  2007cited by this paper
• Complement and Toll-like receptors: key regulators of adaptive immune responses.

  2006cited by this paper
• Recognition of Staphylococcus aureus by the Innate Immune System

  2005cited by this paper
• The dark side of C5a in sepsis

  2004influential reference
• Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.

  2004cited by this paper
• Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units

  2004cited by this paper
• Highly Purified Lipoteichoic Acid from Staphylococcus aureus Induces Procoagulant Activity and Tissue Factor Expression in Human Monocytes but Is a Weak Inducer in Whole Blood: Comparison with Peptidoglycan

  2004cited by this paper
• Lipoteichoic Acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved*

  2003influential reference
• Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment.

  2003cited by this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cited by this paper
• Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

  2003cited by this paper
• Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

  2002cited by this paper
• Role of lipoteichoic acid in infection and inflammation.

  2002influential reference
• Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

  2002cited by this paper
• The immunopathogenesis of sepsis

  2002cited by this paper
• A Novel Role of Complement: Mice Deficient in the Fifth Component of Complement (C5) Exhibit Impaired Liver Regeneration1

  2001cited by this paper
• Complement. First of two parts.

  2001cited by this paper
• Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes by Aspergillus fumigatus Hyphae

  2001cited by this paper
• Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model

  2000cited by this paper
• Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

  1999cited by this paper
• Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

  1999cited by this paper
• Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products*

  1999cited by this paper
• Mechanism of Gram-positive Shock: Identification of Peptidoglycan and Lipoteichoic Acid Moieties Essential in the Induction of Nitric Oxide Synthase, Shock, and Multiple Organ Failure

  1998cited by this paper
• Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses

  1995cited by this paper
• The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

  1995cited by this paper
• Complement activation in septic baboons detected by neoepitope‐specific assays for C3b/iC3b/C3c, C5a and the terminal C5b‐9 complement complex (TCC)

  1993cited by this paper
• Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex

  1985cited by this paper
• American association of critical-care nurses.

  1975cited by this paper
• The epidemiology of sepsis.

  1973cited by this paper

• Inhibition of Alternative and Terminal Complement Pathway Components Modulate the Immune Response Against Bacteria and Fungi in Whole Blood

  2025cites this paper
• Inhibition of the complement component C5 and the Toll-like receptor molecule CD14 prevents systemic and local kidney inflammation in mice experiencing brain death

  2025cites this paper
• Association analysis between CD14 gene polymorphisms and peri‐implantitis susceptibility in a Chinese population

  2024cites this paper
• The complement system: A key player in the host response to infections

  2024cites this paper
• Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model

  2023cites this paper
• A novel selective leukocyte depletion human whole blood model reveals the specific roles of monocytes and granulocytes in the cytokine response to Escherichia coli.

  2023cites this paper
• Staphylococcus aureus induces a muted host response in human blood that blunts the recruitment of neutrophils

  2022cites this paper
• Mapping disease regulatory circuits at cell-type resolution from single-cell multiomics data

  2022cites this paper
• Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research - 20 years of experience and future perspectives.

  2022cites this paper
• Inhibition of CL-11 reduces pulmonary inflammation in a mouse model of Klebsiella pneumoniae lung infection.

  2022cites this paper
• Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood

  2021cites this paper
• Vitamin C, Hydrocortisone, and the Combination Thereof Significantly Inhibited Two of Nine Inflammatory Markers Induced by Escherichia Coli But Not by Staphylococcus Aureus – When Incubated in Human Whole Blood

  2021cites this paper
• Early-Stage Staphylococcus aureus Bloodstream Infection Causes Changes in the Concentrations of Lipoproteins and Acute-Phase Proteins and Is Associated with Low Antibody Titers against Bacterial Virulence Factors

  2020cites this paper
• Innate Immune Response against Staphylococcus aureus Preincubated with Subinhibitory Concentration of trans-Anethole

  2020cites this paper
• TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram‐positive bacteria

  2020cites this paper
• Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.

  2019cites this paper
• Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection

  2019cites this paper
• Immune Evasion by Staphylococcus aureus

  2019cites this paper
• Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditis

  2019cites this paper
• LPS priming in early life decreases antigen uptake of dendritic cells via NO production.

  2018cites this paper
• Association of CD14 rs2569190 polymorphism with mortality in shock septic patients who underwent major cardiac or abdominal surgery: A retrospective study

  2018cites this paper
• Staphylococcus aureus‐induced complement activation promotes tissue factor‐mediated coagulation

  2018cites this paper
• Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes.

  2018cites this paper
• Aalborg Universitet Complement C 3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes Lausen

  2018cites this paper
• Targeting innate immune pathways in acute infectious and sterile inflammation – The role of complement

  2017cites this paper
• A global perspective on hepatitis B‐related single nucleotide polymorphisms and evolution during human migration

  2017cites this paper
• Mechanisms of complement activation under hemolytic conditions

  2017cites this paper
• Activation of the endothelium by pathogen-associated molecular patterns from Escherichia coli and Staphylococcus aureus

  2017cites this paper
• Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus

  2017influential citation
• Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways

  2016cites this paper
• Ratio of T-Helper Type 1 (Th1) to Th17 Cytokines in Whole Blood Is Associated With Human β-Defensin 3 Expression in Skin and Persistent Staphylococcus aureus Nasal Carriage.

  2016cites this paper
• Effects of Polysaccharide Intercellular Adhesin ( PIA ) in an ex vivo model of whole blood 1 killing and in prosthetic joint infection ( PJI ) : a role for C 5 a 2 3 1

  2016cites this paper
• Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4–MD2 Complex

  2016cites this paper
• Alternative pathway regulation by factor H modulates Streptococcus pneumoniae induced proinflammatory cytokine responses by decreasing C5a receptor crosstalk.

  2016cites this paper
• Open Peer Review

  2016cites this paper
• Agents to reduce cytokine storm

  2016cites this paper
• Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood

  2016cites this paper
• Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets

  2016cites this paper
• Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis

  2015influential citation
• A Second Stimulus Required for Enhanced Antifungal Activity of Human Neutrophils in Blood Is Provided by Anaphylatoxin C5a

  2015cites this paper
• Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention

  2015cites this paper
• Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.

  2015influential citation
• Effects of polysaccharide intercellular adhesin (PIA) in an ex vivo model of whole blood killing and in prosthetic joint infection (PJI): A role for C5a.

  2015cites this paper
• The anti‐inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load

  2015cites this paper
• Combined inhibition of complement and CD14 in human experimentally induced bacterial inflammation and in porcine sepsis

  2015cites this paper
• Activated Complement Factors as Disease Markers for Sepsis

  2015cites this paper
• TLR8 Senses Staphylococcus aureus RNA in Human Primary Monocytes and Macrophages and Induces IFN-β Production via a TAK1–IKKβ–IRF5 Signaling Pathway

  2015cites this paper
• Blood Is Provided by Anaphylatoxin C5a Antifungal Activity of Human Neutrophils in A Second Stimulus Required for Enhanced

  2014cites this paper
• Neutrophil-Mediated Phagocytosis of Staphylococcus aureus

  2014influential citation
• Anaphylatoxin C 5 a Antifungal Activity of Human Neutrophils in A Second Stimulus Required for Enhanced

  2014cites this paper
• Agents to reduce cytokine storm [version 1; peer review: 3 approved]

  year unknowncites this paper